Ladenburg analyst Jon Hickman lowered the firm’s price target on Core Scientific (CORZ) to $23.75 from $24.50 and keeps a Buy rating on the shares. The firm is refining its earnings models for both 2026 and 2027 to account for Q4 results and the ongoing expansion in the company’s HPC segment, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
COZX: an alternative to margin or options on CORZPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Core Scientific price target lowered to $25 from $27 at Clear Street
- Closing Bell Movers: MongoDB down over 20% after soft Q1 guidance
- Core Scientific pivots to high-density colocation amid restatements
- Core Scientific reports Q4 EPS 42c vs (69c) last year
- Core Scientific, Inc options imply 16.4% move in share price post-earnings